Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tacrolimus vs hydrocortisone for flexural psoriasis
2004-003835-30Phase 4Terminated
- Sponsor
- Belfast City Hospital
- Start
- Jul 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of Envarsus XR in psoriasis (2 arms), sponsored by Belfast City Hospital. Primary endpoints: Local psoriasis score index change by treatment group and Safety comparison between tacrolimus and hydrocortisone. Started Jul 2005; status: terminated.
02
Drugs
Envarsus XR
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2004-003835-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003835-30.